Stockfacts
Use CasesDocsPricing
Log inSign up free
OverviewFinancialsTrendsTranscriptsOptionsShortsInstitutionsInsidersCorporate ActionsSEC Filings
Stockfacts

EOD US-equity data for investors and AI agents

Data is end-of-day, not real-time, and not investment advice

Use CasesDashboard

ACRS

Aclaris Therapeutics, Inc.

CIK 0001557746 · Nasdaq

NasdaqHealth CarePharmaceutical Preparations
$6.41
↑ 0.08 (1.26%)
as of Aug 21, 2026
End-of-day close, not real-time intraday
Live price (Google Finance) ↗
Overall read: NeutralOverall score · based on 4/4 lenses
FundamentalsOwnershipTechnicalsOptions

Bullish: Ownership, Technicals; Risks: Fundamentals

Key stats

Market Cap
$943.55M
P/E Ratio
-12.46
EPS
-0.53
Dividend Yield
Not covered
52W Position
98%
Beta
0.58

Valuation multiples

Fwd P/E
Not covered
PEG
-0.13
P/B
7.57
P/S
114.80
EV/Revenue
112.47
ROE
-60.8%
Valuation data covers 8,711/9,697 US-listed stocks (89.8%).

Price · 1Y

251 trading days

End-of-day close, not real-time intraday

52-Week RangePosition 98%
$1.74$6.51

Latest Financials

2025-12-31 FY
Revenue
$7.83M
Net Income
-$64.92M
Total Assets
$160.46M
Free Cash Flow
-$47.22M

Recent news